“When Heptares formed, we chose to focus on GPCRs because we knew that targeting these receptors leads to drugs,” says Matt Barnes, president and head of R&D at Nxera Pharma. GPCRs are involved in a ...
Investors in Structure Therapeutics Inc (Symbol: GPCR) saw new options become available this week, for the April 2026 expiration. One of the key inputs that goes into the price an option buyer is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results